Skip to content


  • Letter to the Editor
  • Open Access

Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants

Gynecological SurgeryEndoscopic Imaging and Allied Techniques201714:28

  • Received: 17 July 2017
  • Accepted: 10 December 2017
  • Published:


We read with great interest this potentially landmark survey by Sirkeci and colleagues investigating the attitudes of UK obstetricians and gynaecologists to the treatment of uterine fibroids [1].

Such surveys, as the authors acknowledge, are plagued by low response rates; however, they can also be subject to significant recall bias and furthermore those who respond to such questionnaires tend to have an interest in the subject matter. It is therefore surprising to find that a third of those who responded would still not set a limit to the number of fibroids removed hysteroscopically. There is increasing evidence that submucous fibroids greater than 4 cm, especially when there are multiple types of fibroids present, should be removed laparoscopically as hysteroscopic resection does not allow complete removal and increases the risk of recurrence [2]. Furthermore, only 43% of respondents who perform open myomectomies would aim to remove all fibroids, resulting in an increased risk of recurrence and the need for secondary intervention, which is known to be significantly less successful than primary interventions particularly with regard to fertility and symptom resolution [3].

Most of the respondents agreed that the more complex operations should be performed by those with more experience; however, conversely, those with more experience were least likely to perform a laparoscopic myomectomy, which in 2017 should be considered the “gold standard” surgical treatment.

It is good to see that the numbers of gynaecologists in the UK performing myomectomies have increased since the previous survey over a decade ago; however, these numbers still remain small. Furthermore, disappointingly, almost 40% of women still do have access to facilities offering uterine artery embolisation.

With regard to perimenopausal women, the number of respondents who would perform myomectomy in this cohort has increased. However, a large proportion of women are still deprived of this uterine sparing option by a considerable number of gynaecologists despite existing evidence to show that myomectomy is as safe in the older woman once the issues surrounding leiomyosarcoma are investigated and discussed [4]. Although myomectomy would not be the first-line treatment of choice for women in this age group, many patients do wish to conserve their uterus and they should be given adequate information and counselling to allow them to make an informed choice.

Finally, with the changing face of the gynaecological workforce in the UK as reiterated by this survey, though the authors advise caution in the interpretation of the results, it sends a clear message of disparity in the availability of the various different treatment modalities for fibroids. It is thus important that we re-evaluate the management options for such women and perhaps consider setting up specialised tertiary referral centres to allow all women access to experienced surgeons who would take a holistic multidisciplinary approach to management and have access to all the various treatment modalities in line with what is readily available to women with endometriosis via the “BSGE badged” endometriosis centres.



Nothing to declare.


Not applicable.

Availability of data and materials

Not applicable.

Authors’ contributions

RM and FO both participated in the manuscript writing, and both authors approved the final manuscript.

Authors’ information

Nothing to declare.

Ethics approval and consent to participate

Not required.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

Department of Gynaecology, Barts Health NHS Trust, Whipps Cross University Hospital, London, E11 1NR, UK


  1. Sirkeci RF, Belli AM, Manyonda IT (2017) Treating symptomatic uterine fibroids with myomectomy: current practice and views of UK consultants. Gynecol Surg 14(1):11View ArticlePubMedPubMed CentralGoogle Scholar
  2. Wang CJ, HT Y, PJ W, Su H, KY W, Han CM (2013) Laparoscopic myomectomy instead of hysteroscopic myomectomy for large submucous fibroids. Gynecol Minim Invasive Ther 2(3):93–95View ArticleGoogle Scholar
  3. Frederick J, Hardie M, Reid M, Fletcher H, Wynter S, Frederick C (2002) Operative morbidity and reproductive outcome in secondary myomectomy: a prospective cohort study. Hum Reprod 17(11):2967–2971View ArticlePubMedGoogle Scholar
  4. Odejinmi F, Maclaran K, Agarwal N (2015) Laparoscopic treatment of uterine fibroids: a comparison of peri-operative outcomes in laparoscopic hysterectomy and myomectomy. Arch Gynecol Obstet 291(3):579–584View ArticlePubMedGoogle Scholar


© The Author(s). 2017